Singh TG - Search Results

1

Pharmacological Postconditioning by Protocatechuic Acid Attenuates Brain Injury in Ischemia-Reperfusion (I/R) Mice Model: Implications of Nuclear Factor Erythroid-2-Related Factor Pathway.

Khan H, Grewal AK, Kumar M, Singh TG. Khan H, et al. Among authors: singh tg. Neuroscience. 2022 May 21;491:23-31. doi: 10.1016/j.neuroscience.2022.03.016. Epub 2022 Mar 18. Neuroscience. 2022. PMID: 35314251

2

Involvement of CCR-2 chemokine receptor activation in ischemic preconditioning and postconditioning of brain in mice.

Rehni AK, Singh TG. Rehni AK, et al. Among authors: singh tg. Cytokine. 2012 Oct;60(1):83-9. doi: 10.1016/j.cyto.2012.05.009. Epub 2012 Jun 15. Cytokine. 2012. PMID: 22704692

3

Neuroprotective effect of pharmacological postconditioning on cerebral ischaemia-reperfusion-induced injury in mice.

Grewal AK, Singh N, Singh TG. Grewal AK, et al. Among authors: singh n, singh tg. J Pharm Pharmacol. 2019 Jun;71(6):956-970. doi: 10.1111/jphp.13073. Epub 2019 Feb 27. J Pharm Pharmacol. 2019. PMID: 30809806

4

Effects of resveratrol postconditioning on cerebral ischemia in mice: role of the sirtuin-1 pathway.

Grewal AK, Singh N, Singh TG. Grewal AK, et al. Among authors: singh n, singh tg. Can J Physiol Pharmacol. 2019 Nov;97(11):1094-1101. doi: 10.1139/cjpp-2019-0188. Epub 2019 Jul 24. Can J Physiol Pharmacol. 2019. PMID: 31340128

5

Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.

Sharma V, Kaur A, Singh TG. Sharma V, et al. Among authors: singh tg. Biomed Pharmacother. 2020 Sep;129:110373. doi: 10.1016/j.biopha.2020.110373. Epub 2020 Jun 27. Biomed Pharmacother. 2020. PMID: 32603894 Free article. Review.

6

Novel Targets Explored in the Treatment of Alcohol Withdrawal Syndrome.

Gupta A, Khan H, Kaur A, Singh TG. Gupta A, et al. Among authors: singh tg. CNS Neurol Disord Drug Targets. 2021;20(2):158-173. doi: 10.2174/1871527319999201118155721. CNS Neurol Disord Drug Targets. 2021. PMID: 33213357 Review.

7

Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases.

Thapa K, Khan H, Sharma U, Grewal AK, Singh TG. Thapa K, et al. Among authors: singh tg. Life Sci. 2021 Feb 15;267:118975. doi: 10.1016/j.lfs.2020.118975. Epub 2020 Dec 31. Life Sci. 2021. PMID: 33387580 Review.

8

Pharmacological postconditioning: a molecular aspect in ischemic injury.

Khan H, Kashyap A, Kaur A, Singh TG. Khan H, et al. Among authors: singh tg. J Pharm Pharmacol. 2020 Nov;72(11):1513-1527. doi: 10.1111/jphp.13336. Epub 2020 Jul 28. J Pharm Pharmacol. 2020. PMID: 33460133 Review.

9

Therapies modulating insulin resistance in Parkinson's disease: A cross talk.

Sharma T, Kaur D, Grewal AK, Singh TG. Sharma T, et al. Among authors: singh tg. Neurosci Lett. 2021 Apr 1;749:135754. doi: 10.1016/j.neulet.2021.135754. Epub 2021 Feb 18. Neurosci Lett. 2021. PMID: 33610666 Review.

10

Therapeutic modulation of the phosphatidylinositol 3-kinases (PI3K) pathway in cerebral ischemic injury.

Khan H, Singh A, Thapa K, Garg N, Grewal AK, Singh TG. Khan H, et al. Among authors: singh a, singh tg. Brain Res. 2021 Mar 2:147399. doi: 10.1016/j.brainres.2021.147399. Online ahead of print. Brain Res. 2021. PMID: 33662337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters